GRI Index
This report aligns with the GRI G3 Guidelines. Baxter self-declares this report to application level B. Please also see how Baxter addresses G3 reporting principles.
| DISCLOSURE | DESCRIPTION | 2008 REPORTING | |
| STRATEGY AND ANALYSIS | |||
| 1.1 | Statement from the most senior decision-maker of the organization about the relevance of sustainability to the organization and its strategy. | Chairman and CEO Letter | |
| 1.2 | Description of key impacts, risks, and opportunities. | Chairman and CEO Letter Priorities and Goals |
|
| ORGANIZATIONAL PROFILE | |||
| 2.1 | Name of the organization. | Company Profile | |
| 2.2 | Primary brands, products, and/or services. | Company Profile | |
| 2.3 | Operational structure of the organization, including main divisions, operating companies, subsidiaries, and joint ventures. | Company Profile | |
| 2.4 | Location of organization's headquarters. | Baxter's headquarters are located in Deerfield, Illinois, United States, approximately 20 miles north of Chicago. | |
| 2.5 | Number of countries where the organization operates, and names of countries with either major operations or that are specifically relevant to the sustainability issues covered in the report. | Company Profile | |
| 2.6 | Nature of ownership and legal form. | Baxter Healthcare Corporation (BAX) is a publicly traded company listed on the New York Stock Exchange. | |
| 2.7 | Markets served. | Company Profile | |
| 2.8 | Scale of the reporting organization. | Company Profile Employees Environment, Health and Safety |
|
| 2.9 | Significant changes during the reporting period regarding size, structure, or ownership. | Company Profile | |
| 2.10 | Awards received in the reporting period. | Awards and Honors | |
| REPORT PARAMETERS | |||
| 3.1 | Reporting period for information provided. | Sustainability Reporting | |
| 3.2 | Date of most recent previous report (if any). | Report Downloads | |
| 3.3 | Reporting cycle. | Sustainability Reporting | |
| 3.4 | Contact point for questions regarding the report or its contents. | Sustainability Reporting | |
| 3.5 | Process for defining report content. | Baxter's Approach Priorities and Goals External Reporting Standards |
|
| 3.6 | Boundary of the report. | Sustainability Reporting Environment, Health and Safety |
|
| 3.7 | State any specific limitations on the scope or boundary of the report. | Sustainability Reporting Environment, Health and Safety |
|
| 3.8 | Basis for reporting on joint ventures, subsidiaries, leased facilities, outsourced operations, and other entities that can significantly affect comparability from period to period and/or between organizations. | Sustainability Reporting Environment, Health and Safety |
|
| 3.9 | Data measurement techniques and the bases of calculations, including assumptions and techniques underlying estimations applied to the compilation of the Indicators and other information in the report. | 2008 Environmental Financial Statement Community Support Good EHS Reporting Principles |
|
| 3.10 | Explanation of the effect of any re-statements of information provided in earlier reports, and the reasons for such re-statement. | EHS 2010 Goals | |
| 3.11 | Significant changes from previous reporting periods in the scope, boundary, or measurement methods applied in the report. | Baxter Energy Usage and Greenhouse Gas Emissions 2008 Political Contributions Report |
|
| 3.12 | Table identifying the location of the Standard Disclosures in the report. | GRI Index | |
| 3.13 | Policy and current practice with regard to seeking external assurance for the report. | Assurance | |
| GOVERNANCE, COMMITMENTS AND ENGAGEMENT | |||
| 4.1 | Governance structure of the organization, including committees under the highest governance body responsible for specific tasks, such as setting strategy or organizational oversight. | Corporate Governance | |
| 4.2 | Indicate whether the Chair of the highest governance body is also an executive officer. | Corporate Governance | |
| 4.3 | For organizations that have a unitary board structure, state the number of members of the highest governance body that are independent and/or non-executive members. | Corporate Governance | |
| 4.4 | Mechanisms for shareholders and employees to provide recommendations or direction to the highest governance body. | How to Contact Baxter's Board of Directors | |
| 4.5 | Linkage between compensation for members of the highest governance body, senior managers, and executives (including departure arrangements), and the organization's performance (including social and environmental performance). | Baxter's Compensation Committee and Committee Charter | |
| 4.6 | Processes in place for the highest governance body to ensure conflicts of interest are avoided. | Ethics and Compliance – Code of Conduct | |
| 4.7 | Process for determining the qualifications and expertise of the members of the highest governance body for guiding the organization's strategy on economic, environmental, and social topics. | Corporate Governance Guidelines | |
| 4.8 | Internally developed statements of mission or values, codes of conduct, and principles relevant to economic, environmental, and social performance and the status of their implementation. | Corporate Governance Ethics and Compliance – Code of Conduct Talent Management Global Inclusion EHS – Policy and Vision GHG Emissions and Climate Change Bioethics Clinical Trials Managing Supplier Performance Product Donations and Grants Good EHS Reporting Principles |
|
| 4.9 | Procedures of the highest governance body for overseeing the organization's identification and management of economic, environmental, and social performance, including relevant risks and opportunities, and adherence or compliance with internationally agreed standards, codes of conduct, and principles. | Corporate Governance | |
| 4.10 | Processes for evaluating the highest governance body's own performance, particularly with respect to economic, environmental, and social performance. | Corporate Governance Guidelines | |
| 4.11 | Explanation of whether and how the precautionary approach or principle is addressed by the organization. | Baxter's products are regulated by health authorities around the world and the company is required to provide extensive scientific data related to the safety and efficacy of those products in order to obtain licensure by regulatory authorities. See also Materials Use. | |
| 4.12 | Externally developed economic, environmental, and social charters, principles, or other initiatives to which the organization subscribes or endorses. | Affiliations and Memberships EHS Management Systems GHG Emissions and Climate Change Animal Welfare Clinical Trials Managing Supplier Performance Greening the Supply Chain Public Policy External Reporting Standards |
|
| 4.13 | Memberships in associations and/or national/international advocacy organizations. | Affiliations and Memberships | |
| 4.14 | List of stakeholder groups engaged by the organization. | Stakeholder Engagement | |
| 4.15 | Basis for identification and selection of stakeholders with whom to engage. | Stakeholder Engagement | |
| 4.16 | Approaches to stakeholder engagement, including frequency of engagement by type and by stakeholder group. | Stakeholder Engagement | |
| 4.17 | Key topics and concerns that have been raised through stakeholder engagement, and how the organization has responded to those key topics and concerns, including through its reporting. | Environment, Health and Safety Feedback on 2007 Report |
|
| ECONOMIC | |||
| Disclosure on Management Approach | Economic Impacts Direct Impacts Indirect Impacts |
||
| EC1 | Economic value generated and distributed, including revenues, operating costs, employee compensation, donations and other community investments, retained earnings, and payments to capital providers and governments. (Core) | Direct Impacts | |
| EC2 | Financial implications and other risks and opportunities for the organization's activities due to climate change. (Core) | Baxter considers its exposure to potential regulatory, physical and other risks related to climate change to be very low. The company believes existing and anticipated government policies, legislation, regulations and energy standards aimed at improving energy efficiency and limiting and reducing greenhouse gas (GHG) emissions will pose minimal regulatory risk to the corporation, in part due to Baxter’s proactive approach in this area. In the near-term, Baxter anticipates minimal physical risk to its business associated with global warming, resultant climate change, sea-level rise, change in weather patterns and precipitation. For more information, see Baxter’s Carbon Disclosure Project submission. For more information, see Carbon Disclosure Project submission. | |
| EC3 | Coverage of the organization's defined benefit plan obligations. (Core) | 2008 Annual Report (page 75) | |
| EC4 | Significant financial assistance received from government. (Core) | Not available on a companywide basis. | |
| EC5 | Range of ratios of standard entry level wage compared to local minimum wage at significant locations of operation. (Additional) | ||
| EC6 | Policy, practices, and proportion of spending on locally-based suppliers at significant locations of operation. (Core) | Supplier Diversity | |
| EC7 | Procedures for local hiring and proportion of senior management hired from the local community at significant locations of operation. (Core) | Baxter does not track this information globally. | |
| EC8 | Development and impact of infrastructure investments and services provided primarily for public benefit through commercial, in-kind, or pro bono engagement. (Core) | Community Support | |
| EC9 | Understanding and describing significant indirect economic impacts, including the extent of impacts. (Additional) | Indirect Impacts | |
| ENVIRONMENTAL | |||
| Disclosure on Management Approach | EHS Program | ||
| EN1 | Materials used by weight or volume. (Core) | Eco-Efficiency / Raw Materials Use | |
| EN2 | Percentage of materials used that are recycled input materials. (Core) | Eco-Efficiency / Raw Materials Use | |
| EN3 | Direct energy consumption by primary energy source. (Core) | Management of Energy Use and Cost | |
| EN4 | Indirect energy consumption by primary source. (Core) | Management of Energy Use and Cost | |
| EN5 | Energy saved due to conservation and efficiency improvements. (Additional) | Management of Energy Use and Cost | |
| EN6 | Initiatives to provide energy-efficient or renewable energy based products and services, and reductions in energy requirements as a result of these initiatives. (Additional) | GHG Emissions and Climate Change Carbon-Neutral Products in the United Kingdom |
|
| EN7 | Initiatives to reduce indirect energy consumption and reductions achieved. (Additional) | Management of Energy Use and Cost |
|
| EN8 | Total water withdrawal by source. (Core) | Water and Wastewater | |
| EN9 | Water sources significantly affected by withdrawal of water. (Additional) | ||
| EN10 | Percentage and total volume of water recycled and reused. (Additional) | ||
| EN11 | Location and size of land owned, leased, managed in, or adjacent to, protected areas and areas of high biodiversity value outside protected areas. (Core) | Biodiversity | |
| EN12 | Description of significant impacts of activities, products, and services on biodiversity in protected areas and areas of high biodiversity value outside protected areas. (Core) | Biodiversity | |
| EN13 | Habitats protected or restored. (Additional) | Biodiversity | |
| EN14 | Strategies, current actions, and future plans for managing impacts on biodiversity. (Additional) | Biodiversity | |
| EN15 | Number of IUCN Red List species and national conservation list species with habitats in areas affected by operations, by level of extinction risk. (Additional) | ||
| EN16 | Total direct and indirect greenhouse gas emissions by weight. (Core) | GHG Emissions and Climate Change | |
| EN17 | Other relevant indirect greenhouse gas emissions by weight. (Core) | GHG Emissions and Climate Change | |
| EN18 | Initiatives to reduce greenhouse gas emissions and reductions achieved. (Additional) | GHG Emissions and Climate Change | |
| EN19 | Emissions of ozone-depleting substances by weight. (Core) | Air Emissions | |
| EN20 | NOx, SOx, and other significant air emissions by type and weight. (Core) | Air Emissions | |
| EN21 | Total water discharge by quality and destination. (Core) | Water and Wastewater | |
| EN22 | Total weight of waste by type and disposal method. (Core) | Waste | |
| EN23 | Total number and volume of significant spills. (Core) | Environmental Compliance | |
| EN24 | Weight of transported, imported, exported, or treated waste deemed hazardous under the terms of the Basel Convention Annex I, II, III, and VIII, and percentage of transported waste shipped internationally. (Additional) | ||
| EN25 | Identity, size, protected status, and biodiversity value of water bodies and related habitats significantly affected by the reporting organization's discharges of water and runoff. (Additional) | ||
| EN26 | Initiatives to mitigate environmental impacts of products and services, and extent of impact mitigation. (Core) | Product Sustainability Review Materials Use Manufacturing Product Transport Packaging Product End-of-Life Materials Restrictions Carbon-Neutral Products in the United Kingdom |
|
| EN27 | Percentage of products sold and their packaging materials that are reclaimed by category. (Core) | The European Union packaging directive requires Baxter to reclaim packaging and to submit related reports. Baxter typically pays third parties a fee of about $1 million per year to do this, as indicated on the company's Environmental Financial Statement. Baxter does not currently have systems to track quantities of packaging materials reclaimed. Baxter's products are primarily disposable medical products. Reclamation of these products is difficult since often they must be disposed of as biohazardous waste after their use. Baxter continues to explore means to reclaim and recycle products with its customers. | |
| EN28 | Monetary value of significant fines and total number of non-monetary sanctions for non-compliance with environmental laws and regulations. (Core) | Environmental Compliance | |
| EN29 | Significant environmental impacts of transporting products and other goods and materials used for the organization's operations, and transporting members of the workforce. (Additional) | Product Transport Energy Usage and Cost Management |
|
| EN30 | Total environmental protection expenditures and investments by type. (Additional) | 2008 Environmental Financial Statement | |
| LABOR PRACTICES AND DECENT WORK | |||
| Disclosure on Management Approach | Talent Management Compensation and Benefits Measuring Company Culture Global Inclusion Work/Life |
||
| LA1 | Total workforce by employment type, employment contract, and region. (Core) | Employees | |
| LA2 | Total number and rate of employee turnover by age group, gender, and region. (Core) | Baxter does not track this information globally. | |
| LA3 | Benefits provided to full-time employees that are not provided to temporary or part-time employees, by major operations. (Additional) | Compensation and Benefits Work/Life |
|
| LA4 | Percentage of employees covered by collective bargaining agreements. (Core) | Baxter does not track this information globally. | |
| LA5 | Minimum notice period(s) regarding significant operational changes, including whether it is specified in collective agreements. (Core) | The length of the notice period is dependent on the type of change being made. Baxter is committed to providing appropriate notice and follows all relevant consultation and notice requirements. | |
| LA6 | Percentage of total workforce represented in formal joint management-worker health and safety committees that help monitor and advise on occupational health and safety programs. (Additional) | ||
| LA7 | Rates of injury, occupational diseases, lost days, and absenteeism, and number of work-related fatalities by region. (Core) | 2008 Health and Safety Performance | |
| LA8 | Education, training, counseling, prevention, and risk-control programs in place to assist workforce members, their families, or community members regarding serious diseases. (Core) | Product Development Product Donations and Grants |
|
| LA9 | Health and safety topics covered in formal agreements with trade unions. (Additional) | ||
| LA10 | Average hours of training per year per employee by employee category. (Core) | Talent Management | |
| LA11 | Programs for skills management and lifelong learning that support the continued employability of employees and assist them in managing career endings. (Additional) | Talent Management | |
| LA12 | Percentage of employees receiving regular performance and career development reviews. (Additional) | Talent Management | |
| LA13 | Composition of governance bodies and breakdown of employees per category according to gender, age group, minority group membership, and other indicators of diversity. (Core) | Global Inclusion | |
| LA14 | Ratio of basic salary of men to women by employee category. (Core) | Baxter does not track this information globally. | |
| HUMAN RIGHTS | |||
| Disclosure on Management Approach | Managing Supplier Performance | ||
| HR1 | Percentage and total number of significant investment agreements that include human rights clauses or that have undergone human rights screening. (Core) | Baxter does not track this information globally in a consistent manner. See also Managing Supplier Performance. | |
| HR2 | Percentage of significant suppliers and contractors that have undergone screening on human rights and actions taken. (Core) | Managing Supplier Performance | |
| HR3 | Total hours of employee training on policies and procedures concerning aspects of human rights that are relevant to operations, including the percentage of employees trained. (Additional) | ||
| HR4 | Total number of incidents of discrimination and actions taken. (Core) | Baxter’s Ethics and Compliance helpline and information management system logged 14 allegations of discrimination or harassment in 2008. Baxter encourages employees to seek guidance and report concerns through a number of formal channels. Through these channels, Baxter identifies incidents, prevents incidents from occurring and addresses issues when they do arise. Items identified through these channels help Ethics and Compliance managers identify key risks, develop appropriate training, and design and apply compliance assessment methodologies. View a list of inquiry topics. | |
| HR5 | Operations identified in which the right to exercise freedom of association and collective bargaining may be at significant risk, and actions taken to support these rights. (Core) | See Baxter’s Code of Conduct, page 9. | |
| HR6 | Operations identified as having significant risk for incidents of child labor, and measures taken to contribute to the elimination of child labor. (Core) | See Baxter’s Code of Conduct, page 9. | |
| HR7 | Operations identified as having significant risk for incidents of forced or compulsory labor, and measures to contribute to the elimination of forced or compulsory labor. (Core) | See Baxter’s Code of Conduct, page 9. | |
| HR8 | Percentage of security personnel trained in the organization's policies or procedures concerning aspects of human rights that are relevant to operations. (Additional) | ||
| HR9 | Total number of incidents of violations involving rights of indigenous people and actions taken. (Additional) | ||
| SOCIETY | |||
| Disclosure on Management Approach | Ethics and Compliance Community Support Access to Healthcare Critical Community Needs Employee Involvement |
||
| SO1 | Nature, scope, and effectiveness of any programs and practices that assess and manage the impacts of operations on communities, including entering, operating, and exiting. (Core) | Environment, Health and Safety | |
| SO2 | Percentage and total number of business units analyzed for risks related to corruption. (Core) | Baxter conducts an annual enterprise-wide risk assessment covering, among other things, legal risks such as corruption. Baxter also annually conducts approximately 10-15 intensive assessments of its business units that are designed to evaluate whether Baxter has appropriate anti-corruption policies, processes, controls and training. | |
| SO3 | Percentage of employees trained in organization's anti-corruption policies and procedures. (Core) | Ethics and Compliance – Code of Conduct | |
| SO4 | Actions taken in response to incidents of corruption. (Core) | Ethics and Compliance - Guidance and Compliance | |
| SO5 | Public policy positions and participation in public policy development and lobbying. (Core) | GHG Emissions and Climate Change Public Policy Political Contributions Report |
|
| SO6 | Total value of financial and in-kind contributions to political parties, politicians, and related institutions by country. (Additional) | Political Contributions Report | |
| SO7 | Total number of legal actions for anti-competitive behavior, anti-trust, and monopoly practices and their outcomes. (Additional) | ||
| SO8 | Monetary value of significant fines and total number of non-monetary sanctions for non-compliance with laws and regulations. (Core) | Safety Environmental Compliance Health and Safety Compliance Product Use |
|
| PRODUCT RESPONSIBILITY | |||
| Disclosure on Management Approach | Product Responsibility Quality Safety R&D and Design Materials Use Manufacturing Product Transport Packaging Product Use Product End-of-Life |
||
| PR1 | Life cycle stages in which health and safety impacts of products and services are assessed for improvement, and percentage of significant products and services categories subject to such procedures. (Core) | Product Sustainability Review | |
| PR2 | Total number of incidents of non-compliance with regulations and voluntary codes concerning health and safety impacts of products and services during their life cycle, by type of outcomes. (Additional) | Safety | |
| PR3 | Type of product and service information required by procedures, and percentage of significant products and services subject to such information requirements. (Core) | Clinical Trials Product Use |
|
| PR4 | Total number of incidents of non-compliance with regulations and voluntary codes concerning product and service information and labeling, by type of outcomes. (Additional) | ||
| PR5 | Practices related to customer satisfaction, including results of surveys measuring customer satisfaction. (Additional) | ||
| PR6 | Programs for adherence to laws, standards, and voluntary codes related to marketing communications, including advertising, promotion, and sponsorship. (Core) | Product Use | |
| PR7 | Total number of incidents of non-compliance with regulations and voluntary codes concerning marketing communications, including advertising, promotion, and sponsorship by type of outcomes. (Additional) | Product Use | |
| PR8 | Total number of substantiated complaints regarding breaches of customer privacy and losses of customer data. (Additional) | ||
| PR9 | Monetary value of significant fines for non-compliance with laws and regulations concerning the provision and use of products and services. (Core). | Product Use Safety |
|
